Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epirubicin glucuronidation and UGT2B7 developmental expression.

Matthew J Zaya1, Ronald N Hines, Jeffrey C Stevens

  • 1Pfizer, Inc., Kalamazoo, MI 49001, USA. matthew.j.zaya@pfizer.com

Drug Metabolism and Disposition: the Biological Fate of Chemicals
|September 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four Decades of Cytochrome P450 2B Research: From Protein Adducts to Protein Structures and Beyond.

Drug metabolism and disposition: the biological fate of chemicals·2022
Same author

The Evolution of <i>Drug Metabolism and Disposition</i>: A Perspective From the Editors.

Drug metabolism and disposition: the biological fate of chemicals·2022
Same author

Bringing Big Data to Bear in Environmental Public Health: Challenges and Recommendations.

Frontiers in artificial intelligence·2020
Same author

Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.

Toxicological sciences : an official journal of the Society of Toxicology·2020
Same author

Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans.

Toxicological sciences : an official journal of the Society of Toxicology·2019
Same author

A Time-Embedding Network Models the Ontogeny of 23 Hepatic Drug Metabolizing Enzymes.

Chemical research in toxicology·2019
Same journal

Absorption, metabolism, and excretion of single dose oral [<sup>14</sup>C]camizestrant in healthy human female participants.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Reduction of secondary 3-keto bile acids by aldo-keto reductase 1C1 and 1C4.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Finding the dispersion number (D<sub>N</sub>) of the dispersion model from perfused rat and human liver studies.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.

Drug metabolism and disposition: the biological fate of chemicals·2026
See all related articles

Epirubicin detoxification via UGT2B7-dependent glucuronidation increases with age. This study in pediatric liver microsomes found higher UGT2B7 activity and content in older children and adults, supporting epirubicin use in pediatric patients over six months old.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Pediatric Oncology

Background:

  • Epirubicin offers reduced cardiac toxicity compared to other anthracyclines.
  • UGT2B7-dependent glucuronidation is a key epirubicin detoxification pathway.

Purpose of the Study:

  • To evaluate age-related changes in epirubicin metabolism in pediatric liver microsomes.
  • To assess UGT2B7 activity and expression across pediatric and adult age groups.

Main Methods:

  • Analysis of epirubicin glucuronidation rates in liver microsomes from pediatric and adult donors.
  • Quantification of UGT2B7 enzyme activity and protein levels.
  • Statistical analysis of age-dependent variations.

Main Results:

Related Experiment Videos

  • UGT2B7 activity and content increase with age.
  • Adults showed significantly higher epirubicin glucuronidation than pediatric groups.
  • A positive correlation was observed between UGT2B7 levels and postnatal age.
  • Conclusions:

    • Significant age-related differences in epirubicin glucuronidation and UGT2B7 expression exist within pediatric populations.
    • These findings support the use of epirubicin in pediatric patients aged six months and older.
    • Further research may refine dosing strategies based on age-specific metabolic profiles.